Serum 25-hydroxyvitamin D Concentrations of New Zealanders Aged 15 Years and Older

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2006 Jul 13

PMID 16832715

Citations 37

Authors

J E P Rockell

C M Skeaff

S M Williams

T J Green

Affiliations

Soon will be listed here.

Abstract

Introduction: Vitamin D plays an important role in bone health. Our purpose was to measure serum 25-hydroxyvitamin D concentrations and their determinants in a national sample (n=2,946) of New Zealanders aged 15 years and over.

Findings: Mean (99% CI) serum 25-hydroxyvitamin D concentrations were 47 (45-50) nmol/l in women and 52 (49-55) nmol/l in men. Mean concentrations in New Zealand European and Others (NZEO, n=2,440), Māori (n=370), and Pacific (n=136) were 51 (49-53), 42 (38-46) and 37 (33-42) nmol/l, respectively. Three percent of New Zealanders had serum 25-hydroxyvitamin D concentrations indicative of deficiency (<or=17.5 nmol/l); 48% and 84% were insufficient based on cutoffs of <or=50 and <or=80 nmol/l. Determinants of serum 25-hydroxyvitamin D concentrations in women were age, ethnicity, obesity, latitude and season; determinants in men were ethnicity and season. Serum 25-hydroxyvitamin D in women declined with age; mean concentration was 13 (8-18) nmol/l lower in women 65 years or older and 9 (5-13) nmol/l lower in women 45-64 years compared with women 15-18 years. Spring to summer differences in serum 25-hydroxyvitamin D were 31 (28-34) and 28 (25-31) nmol/l in women and men, respectively. Obese women had lower vitamin status than normal-weight women by 6 (3-10). Women living in the South Island had a mean serum 25-hydroxyvitamin D that was 6 (3-9) nmol/l lower than women living in the North Island. Ethnicity and season are the major determinants of serum 25-hydroxyvitamin D in New Zealanders.

Conclusion: The high prevalence of vitamin D insufficiency in New Zealanders, particularly in older women, may warrant strategies to improve vitamin D status.

Citing Articles

Effects of vitamin D on bone density in healthy children: A systematic review.

Karimian P, Ebrahimi H, Jafarnejad S, Delavar M J Family Med Prim Care. 2022; 11(3):870-878.

PMID: 35495788 PMC: 9051716. DOI: 10.4103/jfmpc.jfmpc_2411_20.

Vitamin D and Kidney Diseases: A Narrative Review.

Vahdat S Int J Prev Med. 2021; 11:195.

PMID: 33815719 PMC: 8000170. DOI: 10.4103/ijpvm.IJPVM_54_19.

Vitamin D history part III: the "modern times"-new questions for orthopaedic practice: deficiency, cell therapy, osteomalacia, fractures, supplementation, infections.

Hernigou P, Sitbon J, Dubory A, Auregan J Int Orthop. 2019; 43(7):1755-1771.

PMID: 31037319 DOI: 10.1007/s00264-019-04334-w.

Assessment of research waste part 2: wrong study populations- an exemplar of baseline vitamin D status of participants in trials of vitamin D supplementation.

Bolland M, Grey A, Avenell A BMC Med Res Methodol. 2018; 18(1):101.

PMID: 30285729 PMC: 6171194. DOI: 10.1186/s12874-018-0555-1.

Effect of vitamin D supplementation on depressive symptoms and psychological wellbeing in healthy adult women: a double-blind randomised controlled clinical trial.

Choukri M, Conner T, Haszard J, Harper M, Houghton L J Nutr Sci. 2018; 7:e23.

PMID: 30197783 PMC: 6123885. DOI: 10.1017/jns.2018.14.

References

Matsuoka L, Wortsman J, Hanifan N, Holick M . Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol. 1988; 124(12):1802-4. View

Bischoff-Ferrari H, Dietrich T, Orav E, Dawson-Hughes B . Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004; 116(9):634-9. DOI: 10.1016/j.amjmed.2003.12.029. View

Holick M . Vitamin D requirements for humans of all ages: new increased requirements for women and men 50 years and older. Osteoporos Int. 1999; 8 Suppl 2:S24-9. DOI: 10.1007/pl00022729. View

Lips P . Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001; 22(4):477-501. DOI: 10.1210/edrv.22.4.0437. View

Reid I, Mackie M, IBBERTSON H . Bone mineral content in Polynesian and white New Zealand women. Br Med J (Clin Res Ed). 1986; 292(6535):1547-8. PMC: 1340554. DOI: 10.1136/bmj.292.6535.1547. View

Randell A, Sambrook P, Nguyen T, Lapsley H, Jones G, Kelly P . Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporos Int. 1995; 5(6):427-32. DOI: 10.1007/BF01626603. View

CHAPUY M, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S . Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int. 2002; 13(3):257-64. DOI: 10.1007/s001980200023. View

Cantorna M, Zhu Y, Froicu M, Wittke A . Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004; 80(6 Suppl):1717S-20S. DOI: 10.1093/ajcn/80.6.1717S. View

Deluca H . Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004; 80(6 Suppl):1689S-96S. DOI: 10.1093/ajcn/80.6.1689S. View

10.

Meunier P, CHAPUY M, Arlot M, Delmas P, Duboeuf F . Can we stop bone loss and prevent hip fractures in the elderly?. Osteoporos Int. 1994; 4 Suppl 1:71-6. DOI: 10.1007/BF01623440. View

11.

John E, Schwartz G, Dreon D, Koo J . Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 1999; 8(5):399-406. View

12.

Bischoff-Ferrari H, Dietrich T, Orav E, Hu F, Zhang Y, Karlson E . Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr. 2004; 80(3):752-8. DOI: 10.1093/ajcn/80.3.752. View

13.

Papadimitropoulos E, Coyte P, Josse R, Greenwood C . Current and projected rates of hip fracture in Canada. CMAJ. 1997; 157(10):1357-63. PMC: 1228461. View

14.

Wortsman J, Matsuoka L, Chen T, Lu Z, Holick M . Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72(3):690-3. DOI: 10.1093/ajcn/72.3.690. View

15.

Bell N, Epstein S, Greene A, Shary J, Oexmann M, Shaw S . Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest. 1985; 76(1):370-3. PMC: 423785. DOI: 10.1172/JCI111971. View

16.

Norton R, Butler M, Currie R, Campbell A, Reid I, Gray H . Hip fracture incidence among older people in Auckland: a population-based study. N Z Med J. 1995; 108(1010):426-8. View

17.

Jacobs E, Giuliano A, Martinez M, Hollis B, Reid M, Marshall J . Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol. 2004; 89-90(1-5):533-7. DOI: 10.1016/j.jsbmb.2004.03.063. View

18.

Looker A, Dawson-Hughes B, Calvo M, Gunter E, Sahyoun N . Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002; 30(5):771-7. DOI: 10.1016/s8756-3282(02)00692-0. View

19.

Lips P, Graafmans W, Ooms M, Bezemer P, Bouter L . Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med. 1996; 124(4):400-6. DOI: 10.7326/0003-4819-124-4-199602150-00003. View

20.

Meier C, Woitge H, Witte K, Lemmer B, Seibel M . Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res. 2004; 19(8):1221-30. DOI: 10.1359/JBMR.040511. View